Patent · US Active

Engineered enzymes

US10655114B1 · kind B1 · utility

10Cited by
16References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 22, 2020
Grant dateMay 19, 2020
Priority date—
Expiry dateFeb 22, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N9/22
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides engineered RNA-guided enzymes for editing live cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.